Locations
Little Chesterford, Saffron Walden CB10 1TU, UK · Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series B
founded in
2016
NodThera is a biotech company focused on developing innovative treatments for chronic inflammatory diseases by targeting the NLRP3 inflammasome. Their approach is based on extensive scientific evidence that positions the NLRP3 inflammasome as a key driver of inflammation, which is implicated in various chronic diseases, including obesity, cardiometabolic disorders, and neurodegenerative conditions. With a strong pipeline of best-in-class molecules and a team of experienced industry leaders, NodThera aims to deliver effective therapies that can significantly improve patient outcomes in these areas. The company is well-positioned in the biotech sector, leveraging its clinical and pre-clinical data to establish itself as a leader in the NLRP3 inflammasome space.
Something looks off?